The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
AbstractsFull Access

Overview of Poster Sessions

Published Online:

POSTER SESSION I – SUNDAY, FEBRUARY 27, 2005 – 5:30 P.M. TO 7:00 P.M

Basic Neuroscience

P1. Zinc-containing amygdaloid efferents to medial prefrontal cortex: histochemical characterization and implications in development. Heather M. Ames, Mette K. Christensen, Jens Christian Sorensen, Francine M. Benes, Miles G. Cunningham

P2. Engraftment of GABAergic neurons into the amygdala attenuates anxiety in the unconditioned light response. Miles G. Cunningham, Caroline M. Connor, Rachael A. Donalds, Edward G. Meloni, Mark S. Todtenkopf, Douglas B. Jacoby, William A. Carlezon.

P3. Transplantation of a monoaminergic cell line into an animal model of depression. Rachael A. Donalds, Dong-Wook Kim, Caroline M. Connor, Susan Anderson, Lee Napierata, Kwang-Soo Kim, Miles G. Cunningham.

P4. Viral tracers and the cerebellum: parallel circuits for neuropsychiatric function. Katherine H. Taber, Peter L. Strick, Robin A. Hurley.

P5. Convergence of amygdalofugal and TH-positive fibers within the adult and developing cingulate cortex. Olga Osadchaya, Francine M. Benes, Miles G. Cunningham.

P6. Corticothalamic connections of the posteromedial cortex in the macaque: implications for the understanding of consciousness and psychosis. Josef Parvizi, Gary W. Van Hoesen, Joseph Buckwalter.

Dementia

P7. Clinical utility of the Frontal Assessment Battery (FAB) in older adults with suspected Alzheimer’s dementia. Brian L. Brooks, Grant L. Iverson.

P8. Measuring change on the Cornell Scale for Depression in Dementia. Grant L. Iverson, Rael T. Lange.

P9. Interpreting change on factor scores for the Neuropsychiatric Inventory-Nursing Home Version. Grant L. Iverson.

P10. Cognitive decline following single known stroke. Gregory Kellermeyer, Nancy M. Bonifer, Kristin M. Anderson, C. Alan Anderson, David B. Arciniegas

P11. NPI behavioral disorder frequencies are similar in DSM-IV-TR and NINCDS-ADRDA severe Alzheimer’s disease in a dementia facility population. Edward C. Lauterbach, Aderonke A. Oguntoye, Angela D. Losert, Samuel D. Shillcutt.

P12. Assessment of apathy and depression prevalence in DSM-IV-TR and NINCDS-ADRDA Alzheimer’s disease at a dementia nursing facility. Edward C. Lauterbach, Aderonke A. Oguntoye, Angela D..Losert, Samuel D. Shillcutt.

P13. Insight in MCI and AD and assessment of quality of life. Rebecca E. Ready, Brian R. Ott, Janet Grace

P14. Predictors of caregiver desire to institutionalize. Mary B. Spitznagel, Geoffrey Tremont, Jennifer D. Davis, Suzanne M. Foster

P15. Relationship satisfaction affects caregiver burden in dementia caregivers. Pamela Steadman, Geoffrey Tremont, Jennifer Davis

P16. High prevalence of impaired graphesthesia in patients with mild cognitive impairment (mci). Edward Zamrini, Atiq Rhaman, Troy Anderson

Epilepsy

P17. Magnetoencephalography aids in neuroanotomic localization of electrophysiologic abnormalities in pediatric epilepsy. Daniel J. Abrams, Paul M. Levisohn, Pramote Laoprasert, Daniel A. Collins, Donald C. Rojas, Martin L. Reite

Imaging

P18. Hippocampus volume loss in alcoholism: a replication study. Thomas P. Beresford, David B. Arciniegas, Julie Alfers, Lori Clapp, Brandon Martin

P19. Cortisol and vulnerability to hippocampus volume loss in alcoholism. Thomas P. Beresford, David B. Arciniegas, Julie Alfers, Lori Clapp, Mark Laudenslager, Brandon Martin

P20. Quantitative pharmacological fmri: a new approach and test of concept. Kevin J. Black, Jacob M. Poulsen, Jonathan M. Koller, Stacie L. Warren, Johanna M. Hartlein

P21. Neuropsychiatry in frontotemporal degeneration correlates with right-sided regional atrophy. Tiffany W. Chow, Malcolm A. Binns, Joel Ramirez, Sandra E. Black

P22. Impact of diagnosis of personality disorder on gray matter volumes in first-episode schizophrenia: a preliminary Voxel-Based Morphometric Analysis. Harpreet S. Duggal, Matcheri S. Keshavan, Jeffery Nutche

P23. Anxiety and regional cortical metabolism in patients with Alzheimer’s disease?. Hiroshi Hashimoto, Lorena Monserratt, Peter Nguyen, Denise Feil, Dylan Harwood, Mark Mandelkern, David Sultze

P24. Volitional action as assessed by magnetoencephalography. Benzi M. Kluger, Donald C. Rojas, Eugene Kronberg, Christopher M. Filley

P25. Donepezil and placebo effects on brain networks and cognition Parkinson’s disease. Marc J. Mentis, Luke Donetelli, Dominique, Delalot, Paul Mattis, Mark Gordon, Vijay Dhawan, David Eidelberg.

P26. Tissue abnormalities in autism detected through voxel-based T2 imaging. Rob Nicolson, Janet Hendry, Timothy DeVito, Neil Gelman, Nagalingam Rajakumar, Peter Williamson, Dick Drost

P27. Interdisciplinary approach for the evaluation of brain SPECT usefulness in optimization of diagnosis and treatment in children with serious learning difficulties and comorbidity. Dan G. Pavel, Paul Cates, Steven Devore-Best, David Woodhouse, Krik Cates, Yu-Ching Chang, Jun Eunsun, Irnina Craita

P28. Brain metabolic correlates of marijuana use: a review of the neuroimaging data. Jeremy Quickfall, David Crockford

Neuropsychology

P29. Borderline Personality Disorder, Impulsivity, and the Orbitofrontal Cortex. Heather A. Berlin, Edmund T. Rolls, Susan D. Iversen.

P30. Can neuropsychological tests predict memory performance on the sodium amytal procedure (Wada)?. Kristine A. Borden, Thomas G. Burns, & Tiffany D. Denton

P31. Neuropsychological aspects of depression subtypes in Parkinson’s disease. Marianne Naomi Findler, Allessandro Di Rocco, John W. Barnhill, James Godbold, Milana D. Veytsman, Oana Petrescu, Lucio Marinelli, Deborah Hesketh, Amy Scarano, Niv Mor, Anne Dalton, Sabina Nasser, Stephen J. Ferrando.

P32. Cognitive performance and quality of life in medication-refractory Parkinson’s disease. N. S. Koven, R. M. Roth, D. J. Coffey, L. A. Flashman, A. J. Saykin

P33. An examination of the neuropsychological properties of the Cognitive Assessment System: a comparison of PASS theory, factor analytic, hierarchical agglomerative cluster analysis and ipsative models in subjects with focal brain lesion. Simon M. McCrea

P34. Comparability of the full and 160-Item Short Form Versions of the Personality Assessment Inventory among patients referred for neuropsychological evaluations: assessing differences in reliability, factor structure, and within-individual agreement. Richard Naugle, Thomas Frazier, Kathryn Haggerty

P35. Theory of mind and decision-making deficits in patients with prefrontal cortex dysfunction. Teresa Torralva, John Hodges, Tristán Bekinschtein, Luke Clark, María Roca, Agustina Lacroze, María Calcagno, Ramón Leiguarda, Facundo Manes

P36. An ecological battery to detect specific executive deficits in patients with early frontal variant of Frontotemporal Dementia (fvFTD). Teresa Torralva

P37. Executive functions in ADHD: the usefulness of an “ecological” battery. Teresa Torralva, Alicia Lischinsky, Agustina Lacroze, María Calcagno, Ramón Leiguarda, Facundo Manes

Schizophrenia

P38. Brain activation patterns associated with listening to trauma-related words and scripts in patients with schizophrenia and posttraumatic stress disorder: a preliminary fMRI study. Laura Fashman, Andrew Saykin, Robert Roth, Robert Vidaver, Matthew Friedman, Paula Schnurr, Thomas McAllister, Kim Mueser, Stanley Rosenberg

P39. A study of frontal executive function using Kims Frontal Executive Function Test in schizophrenia. Jeong-Lan Kim, Kyoung-Ok Lim, IK-Seong Chee, Seong-Kun Wang, Sun-Woo Lee.

P40. Cardiac chaos as a marker of therapeutic response in treatment-resistant schizophrenic subjects treated with clozapine. Jong-Hoon Kim, Sang-Hoon Yi, Yong Min Ahn, Yong Sik Kim

POSTER SESSION II – TUESDAY, MARCH 1, 2005 – 4:30 P.M. TO 6:00 P.M.

General Clinical Neuropsychiatry

P1. Psychiatric comorbidity, disability, and quality of life in psychogenic movement disorder versus Parkinson’s disease. Karen E. Anderson, Ann L. Gruber-Baldini, Christopher G. Vaughan, Stephen G. Reich, Paul Fishman, William J. Weiner, Lisa M. Shulman

P2. Neuroinvasive West Nile Virus infections: neurobehavioral and functional outcomes. David B. Arciniegas, Kimberly Frey, Jeannie L. Topkoff, Kristin M. Brousseau, Eric Hartman, Jeremy Rieks, Miguel Alvarado, Alan Spees, C. Alan Anderson, Donald C. Rojas, Elizabeth Kozora, Kenneth L.Tyler

P3. Towards a collaborative education and treatment of disorders emanating from the central nervous system. Joseph Baskin, Bruce Price, Martin Goldstein, Anthony Joseph, Jennifer Woehr, Rachael Donalds, Miles Cunningham

P4. Neurologic and psychiatric co-morbidity in neuropsychiatry training. R. Andrew Swell, Sheldon Benjamin.

P5. Neurological and neuropsychological abnormalities in imprisoned sexual offenders. Deborah N. Black, Carine Doucet, Benoit Dassylva

P6. Neuropsychiatry as an integrative specialty: paraphrenias and combined subsyndromic presentations in geriatric psychiatry. T. Brashers-Krug, VE Koliatsos

P7. A neuropsychiatric presentation of Lyme disease. Kristin Brousseau, David Iverson

P8. The prevalence of anxiety disorders in a cohort of Multiple Sclerosis patients followed in a neuropsychiatry clinic and the impact of anxiety on the Multiple Sclerosis disease profile. Zeina Chemali, Juan Carlos Urizar

P9. Neuropsychiatry as an integrative specialty for disorders of the peripheral and autonomic nervous system. Thomas N. Franklin, Vassilis E. Koliatsos

P10. Older age immunological measures among HIV-I infected primary Spanish speakers in the USA. Karl Goodkin, Deshratn Asthana, Paul Shapshak, Mauricio Concha, Diana Lee, Sandra O’Mellan, Wenli Zheng, Imad Khamis

P11. Comparative efficacy of extended-release bupropion and escitalopram for major depressive disorder. Joseph P. Horrigan, Jack G. Modell, Donna S. Wightman, Nathalie E. Richard, Alok Krishen.

P12. Neuropsychiatry as an integrative specialty: definitions, patient types, and points of view. Vassilis E. Koliatsos, Robert R. Roca, Steven S. Sharfstein, Ann Newman, Andrew Warren, Thomas Franklin, Thomas Brashers-Krug.

P13. Depression is more strongly associated with subject report than motor signs in PREDICT-HD cohort. Carissa Nehl, Elizabeth A. Penziner, Jane S. Paulsen

P14. Neuromuscular dysfunction and antipsychotic theory. Ilya Reznik, Lior Volchek, Mila Reznik, Avi Weizman, Herbert Y. Meltzer

P15. Psychogenic movement disorder: assessment and antidepressant treatment. Valerie Voon, Anthony E. Lang

Pediatric Neuropsychiatry/Neuropsychology

P16. Insomnia in Tourette syndrome is linked to perinatal factors as well as comorbidities. Marie-Josée Chouinard, Véronique Paradis, Paul Lespérance, Guy Rouleau, Sylvain Chouinard, Francois Richer

P17. Hyperammonemia, carnitine deficiency, cerebral atrophy, and progressive cognitive impairment in three bipolar child patients treated with divalproex sodium. Daniel T. Matthews, Larry Fisher, John Seals

P18. Consequences of abnormal anxiety with congenital central hypoventilation syndrome. Susan Beckwitt Turkel, Maida L. Chen, Julienne R. Jacobson, Thomas G. Keens

P19. The effects of psycho-stimulants on children’s academic achievement in cognitive functioning. Cates Kirk, Cates Paul, Woodhouse David

Traumatic Brain Injury

P20. Effect of age on recovery following severe traumatic brain injury. Benjamin S. Alderfer, Kimberly L. frey, Gergory B. Kellermeyer, Kristin M. BNrousseau, Jeannie L. Topkoff, C. Alan Anderson, Christopher M. Filley, David B. Arciniegas.

P21. Frontal dysfunction is a dominant feature of posttraumatic encephalopathy. Gregory Kellermeyer, Kimberly Frey, Benjamin Alderfer, Jeannie Topkoff, Kristin Brousseau, C.Alan Anderson, Christopher M. Filley, David B. Arciniegas

P22. A prospective study of cognitive enhancement with galantamine increased over four months in patients with traumatic brain injury. John Claude Krusz, Stephen Roberts, Jack Thomson

P23. Donepezil for cognitive enhancement after traumatic brain injury. John Claude Krusz, Alan C. Hopewell, John A. Thomson, Stephen Roberts

P24. Two CHRM2 SNPs modulate working memory performance and anxiety shortly after mild/moderate traumatic brain injury (MTBI). TW McAllister, LA Flashman, CH Rhodes, BC McDonald, DR Belloni, ML Curtis, RB Ferrell, GJ Tsongalis, AJ Saykin.

P25. Use of the frontal systems behavior scale in traumatic brain injury. Sonal Pancholi, Louis French, Farah Said, Laurie Ryan, Deborah Warden

P26. The effect of mild-to-moderate traumatic brain injury and APOE-4 on cognitive outcome in older adults: preliminary results of a two-year longitudinal study. Mark J. Rapoport, Prathiba Shammi, Nathan Herrmann, Andrea L. Phillips, Alex Kiss, Anthony Feinstein.

P27. Hippocampal size correlates with episodic memory performance one month after mild traumatic brain injury. J.L. Sotelo, L.A. Flashman, B.C. McDonald, E.M. Crouse, A.J. Saykin, T.W. McAllister.